Drug Design Development and Therapy,
Journal Year:
2024,
Volume and Issue:
Volume 18, P. 5323 - 5332
Published: Nov. 1, 2024
The
glycolipid
α-galactosylceramide
(α-GalCer),
when
presented
by
CD1d,
can
modulate
the
immune
system
through
activation
of
natural
killer
T
(NKT)
cells.
Previously,
we
synthesized
over
30
analogs
α-GalCer
and
identified
a
compound,
C34,
which
features
two
phenyl
rings
on
acyl
chain.
C34
exhibited
most
potent
NKT-stimulating
activities,
characterized
strong
Th1-biased
cytokines
anti-tumor
effects
in
several
murine
tumor
models.
Importantly,
unlike
α-GalCer,
did
not
induce
NKT
cell
anergy.
Despite
these
promising
results,
clinical
application
is
limited
its
poor
aqueous
solubility.
PEGylation
enhances
solubility
hydrophobic
drugs,
numerous
PEGylated
drugs
have
received
approval.
Consequently,
assessed
biological
activity
this
study.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 4051 - 4051
Published: April 5, 2024
Bacterial
and
viral
respiratory
tract
infections
are
the
most
common
infectious
diseases,
leading
to
worldwide
morbidity
mortality.
In
past
10
years,
importance
of
lung
microbiota
emerged
in
context
pulmonary
although
mechanisms
by
which
it
impacts
intestinal
environment
have
not
yet
been
fully
identified.
On
contrary,
gut
microbial
dysbiosis
is
associated
with
disease
etiology
or/and
development
lung.
this
review,
we
present
an
overview
microbiome
modifications
occurring
during
infections,
namely,
reduced
community
diversity
increased
burden,
downstream
consequences
on
host–pathogen
interaction,
inflammatory
signals,
cytokines
production,
turn
affecting
progression
outcome.
Particularly,
focus
role
gut–lung
bidirectional
communication
shaping
inflammation
immunity
context,
resuming
both
animal
human
studies.
Moreover,
discuss
challenges
possibilities
related
novel
microbial-based
(probiotics
dietary
supplementation)
microbial-targeted
therapies
(antibacterial
monoclonal
antibodies
bacteriophages),
aimed
remodel
composition
resident
communities
restore
health.
Finally,
propose
outlook
some
relevant
questions
field
be
answered
future
research,
may
translational
relevance
for
prevention
control
infections.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 16, 2024
Preclinical
evidence
has
firmly
established
a
bidirectional
interaction
among
the
lung,
gut,
and
gut
microbiome.
There
are
many
complex
communication
pathways
between
lung
intestine,
which
affect
each
other's
balance.
Some
metabolites
produced
by
intestinal
microorganisms,
immune
cells,
factors
enter
tissue
through
blood
circulation
participate
in
function.
Altered
gut-lung-microbiome
interactions
have
been
identified
rodent
models
humans
of
several
diseases
such
as
pulmonary
fibrosis,
chronic
obstructive
disease,
cancer,
asthma,
etc.
Emerging
suggests
that
microbial
therapies
can
prevent
treat
respiratory
diseases,
but
it
is
unclear
whether
this
association
simple
correlation
with
pathological
mechanisms
disease
or
result
causation.
In
review,
we
summarize
critical
link
microbiota
well
influence
mechanism
on
discuss
role
interventions
prebiotics
fecal
bacteria
transplantation
diseases.
To
provide
reference
for
rational
design
large-scale
clinical
studies,
direct
application
therapy
to
respiratory-related
reduce
incidence
severity
accompanying
complications.
Autoimmunity Reviews,
Journal Year:
2024,
Volume and Issue:
23(6), P. 103583 - 103583
Published: June 1, 2024
T
cells
are
key
drivers
of
the
pathogenesis
autoimmune
diseases
by
producing
cytokines,
stimulating
generation
autoantibodies,
and
mediating
tissue
cell
damage.
Distinct
mitochondrial
metabolic
pathways
govern
direction
T-cell
differentiation
function
rely
on
specific
nutrients
enzymes.
Metabolic
substrate
uptake
metabolism
form
foundational
elements
for
activation,
proliferation,
differentiation,
effector
function,
contributing
to
dynamic
interplay
between
immunological
signals
in
coordinating
adaptive
immunity.
Perturbations
availability
enzyme
activity
may
impair
immunosuppressive
fostering
autoreactive
responses
disrupting
immune
homeostasis,
ultimately
disease
pathogenesis.
A
growing
body
studies
has
explored
how
processes
regulate
diverse
subsets
such
as
systemic
lupus
erythematosus
(SLE),
multiple
sclerosis
(MS),
hepatitis
(AIH),
inflammatory
bowel
(IBD),
psoriasis.
This
review
describes
coordination
biology
metabolism,
including
electron
transport
chain
(ETC),
oxidative
phosphorylation,
amino
acid
fatty
one‑carbon
metabolism.
study
elucidated
intricate
crosstalk
programs,
signal
transduction
pathways,
transcription
factors.
summarizes
potential
therapeutic
targets
signaling
diseases,
providing
insights
future
studies.
Environmental Toxicology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 11, 2025
ABSTRACT
Growing
evidence
suggests
an
association
between
various
immune
cell
phenotypes
and
the
development
of
asthma.
However,
it
is
still
not
entirely
clear
whether
specific
might
causally
contribute
to
risk
Despite
further
studies
required
validate
this
claim,
our
study
delves
deeper
into
explaining
relationship
paving
way
toward
new
therapeutic
approaches.
Our
initial
aim
reveal
causal
731
immunocyte
asthma;
a
bidirectional
Mendelian
randomization
(MR)
analysis
was
performed.
We
have
investigated
in
asthma,
using
summary
previously
published
GWAS.
Conducting
MR
analysis,
we
interpreted
potential
causative
them.
analytical
approaches
included
inverse
variance‐weighted
average,
weighted
median
(WM)
modeling,
pattern‐based
To
ensure
robustness
accuracy
findings,
conducted
sensitivity
analyses
employing
MR‐PRESSO,
Cochran's
Q
test,
leave‐one‐out,
MR‐Egger
Additionally,
reverse
examine
causality.
revealed
43
immunophenotypes
with
connection
asthma
risk.
Following
Bonferroni
correction
identified
four
strong
associations
reliability,
them
being:
HLA
DR
on
DC
(95%
CI:
1.0008–1.0014,
p
=
4.26
×
10
−6
,
FDR
2.21
−8
),
CD8
CD28−
CD8br
1.0007–1.0020,
4.01
−5
,FDR
5.70
−4
CD62L
monocyte
0.9985–0.9995,
1.06
9.20
CD8br%
leukocyte
1.0006–1.0019,
1.07
1.14
−3
).
confirmed
large
co‐inheritance
all
these
immunophenotypes,
which
contribution
development.
In
addition,
that
lack
provides
different
phenotypes,
are
either
beneficial
or
detrimental
Given
fact
broad
disease
contains
complex
mechanisms,
research
may
offer
improved
outcomes
long‐term
treatment
strategies.
Scandinavian Journal of Immunology,
Journal Year:
2025,
Volume and Issue:
101(4)
Published: April 1, 2025
ABSTRACT
CD1d
is
an
antigen‐presenting
molecule
that
presents
lipid
or
glycolipid
antigens
to
i
NKT
cells,
a
distinct
subset
of
T
lymphocytes
characterised
by
their
innate‐like
properties
and
restricted
use
V
α
,
J
β
segments.
The
CD1d‐
axis
represents
interesting
aspect
the
immune
system
with
significant
potential
for
therapeutic
interventions
against
infectious
diseases.
Upon
recognition
antigens,
cells
initiate
rapid
potent
responses,
releasing
diverse
array
cytokines
such
as
IL‐4,
IL‐13,
IFN‐γ
etc.
profoundly
influence
reactions
various
pathogens,
including
bacteria
parasites,
bridging
innate
adaptive
immunity.
We
identify
describe
key
features
lipidic
derivatives
determine
nature
antigenicity.
Furthermore,
modulating
CD1d‐driven
cell
responses
holds
promise
adjunctive
therapy
existing
antimicrobial
treatments.
Understanding
complexities
exploiting
its
in
case
diseases
could
lead
innovative
immunotherapeutic
strategies,
ushering
new
era
immunotherapy
pathogenic
insults.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(24), P. 5737 - 5737
Published: Dec. 7, 2023
Invariant
natural
killer
T
cells
(iNKTs),
a
type
of
unconventional
cells,
share
features
with
NK
and
have
an
invariant
cell
receptor
(TCR),
which
recognizes
lipid
antigens
loaded
on
CD1d
molecules,
major
histocompatibility
complex
class
I
(MHC-I)-like
protein.
This
interaction
produces
the
secretion
wide
array
cytokines
by
these
including
interferon
gamma
(IFN-γ)
interleukin
4
(IL-4),
allowing
iNKTs
to
link
innate
adaptive
responses.
Interestingly,
molecules
that
bind
been
identified
enable
modulation
highlighting
their
potential
pro-inflammatory
immunosuppressive
capacities,
as
required
in
different
clinical
settings.
In
this
review,
we
summarize
key
current
understandings
modulatory
α-galactosylceramide
(α-GalCer)
variants,
model
iNKT
activator
can
shift
outcome
immune
Furthermore,
discuss
advances
development
strategies
modulate
target
pathologies
are
considerable
healthcare
burdens.
Finally,
recapitulate
findings
supporting
role
for
infectious
diseases
tumor
immunotherapy.